Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s

Neurobiology of Aging

Volumn 19, Issue 3, 1998, Pages 173-189

  Berchtold, N C ^a   Cotman, C W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Aristotle; Dementia; Esquirol; Fischer; Galen; Greco Roman; History; Kraepelin; Medieval; Neurofibrillary tangles; Neuropathology; Perusini; Psychiatry; Senile dementia; Senile plaques

Indexed keywords

ALZHEIMER DISEASE; DEMENTIA; GREECE; HISTORY; HUMAN; ITALY; PSYCHOLOGICAL ASPECT; REVIEW;

ALZHEIMER DISEASE; DEMENTIA; GREECE; HISTORY, ANCIENT; HUMANS; ROME;

EID: 0032058918     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00052-9     Document Type: Article

References (170)

1. Amyloidosis of Alzheimer's disease: A clue to ageing? Lancet 2:598-9; 1970.
2. Albert, M. S. Cognitive and neurobiologie markers of early Alzheimer disease. Proc. Natl. Acad. Sci. USA 93:13547-51; 1996.
3. Alexander, L.; Looney, J. M. Physicochemical properties of brain, especially in senile dementia and cerebral edema. Arch. Neurol. Psychiat. 40:877-902; 1938.
4. Alzheimer, A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiat. Psych.-Gericht. Med. 64:146-148; 1907.
5. Amaducci, L. A.; Rocca, W. A.; Schoenberg, B. S. Origin of the distinction between Alzheimer's disease and senile dementia: How history can clarify nosology. Neurology 36:1497-1499; 1986.
6. Barrough, P. The methode of phisicke (1583). In: Hunter, R.; Macalpine, I., eds. Three Hundred Years of Psychiatry (1535-1860): A history presented in selected English texts. Hartsdale, New York: Carlisle Publishing; 1982:24-28.
7. Beach, T. G. The history of Alzheimer's disease: 3 debates. J. Hist. Med. Allied Sci. 42:327-349; 1987.
8. Beal, M. F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6:661-6; 1996.
9. Behan, P. O.; Feldman, R. G. Serum proteins, amyloid and Alzheimer's disease. J. Am. Geriatr. Soc. 18:792-7; 1970.
10. Bernai, J. D. The Emergence of Science. Cambridge: M.I.T. Press; 1965.
11. Berrios, G. E. Dementia during the seventeenth and eighteenth centuries: A conceptual history. Psychol. Med. 17:829-837; 1987.
12. Berrios, G. E. Dementia: Historical overview. In: Burns, A.; Levy, R., eds. Dementia. London: Chapman and Hall; 1994:5-19.
13. Bick, K.; Amaducci, L.; Pepeu, G. The Early Story of Alzheimer's Disease. Translation of the historical papers. Padova, Italy: Liviana Press; 1987.
14. Bielschowsky, M. Die Ziele bei Impregnation der Neurofibrillen. Neurol. Centralbl. 22:997-1006; 1903.
15. Bielschowsky, M. Zur Kenntnis der Alzheimerschen Krankheit (präsenilen Demenz mit Herdsymptomen). J. Psychol. Neurol. Lpz. 18:273-292; 1911.
16. Bielschowsky, M. Histopathology of nerve cells. In: Penfield, W., eds. Penfield's Cytology and Cellular Pathology of the Nervous System. New York: Hafner Publishing Co.; 1932:147-188.
17. Birge, S. J. The role of estrogen in the treatment of Alzheimer's disease. Neurology S36-41; 1997.
18. Black, J. E.; Isaacs, K. R.; Greenough, W. T. Usual vs. successful aging: Some notes on experiential factors [comment]. Neurobiol. Aging 12:325-8; discussion 352-5; 1991.
19. Blesa, R.; Mohr, E.; Miletich, R. S.; Hildebrand, K.; Sampson, M.; Chase, T. N. Cerebral metabolic changes in Alzheimer's disease: Neurobehavioral patterns. Dementia 7:239-45; 1996.
20. Blocq, P.; Marinesco, G. Sur les lésions et la pathogénie de l'épilepsie dite essentielle. Semaine Médical 12:445-6; 1892.
21. Boiler, F.; Forette, F. Alzheimer's disease and THA: A review of the cholinergic theory and of preliminary results. Biomed. Pharmacother. 43:487-91; 1989.
22. Bonifiglio, F. Di speciali reperti in un caso di probabile sifilide cerebrale. Rivista Sperim. Freniatria 34:196-206; 1908.
23. Bouman, L. Senile plaques. Brain 57:128-142; 1934.
24. Braak, H.; Braak, E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16:271-8; discussion 278-84; 1995.
25. Breitner, J. C. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol. Aging 17:789-94; 1996.
26. Brooks, D. J. Functional imaging techniques in the diagnosis of non-Alzheimer dementias. J. Neural. Transm. Suppl. 47:155-67; 1996.
27. Cajal, R. y.; Cajal's Degeneration & Regeneration of the Nervous System. New York: Oxford University Press, Inc.; 1928.
28. Chen, S.; Frederickson, R. C.; Brunden, K. R. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches. Neurobiol. Aging 17: 781-7; 1996.
29. Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak, V. M. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [see comments]. Science 261:921-3; 1993.
30. Cotman, C. W.; Anderson, A. J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:19-45; 1995.
31. Cotman, C. W.; Su, J. H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6:493-506; 1996.
32. Crismon, M. L. Tacrine: First drug approved for Alzheimer's disease. Ann. Pharmacother. 28:744-51; 1994.
33. Critchley, M. The neurology of old age, part III. Lancet 1:1331-1337; 1931.
34. Cullen, W. First lines in the practice of physic (1784). In: Hunter, R.; Macalpine, I., eds. Three Hundred Years of Psychiatry (1535-1860): A history presented in selected English texts. Hartsdale, NY: Carlisle Publishing; 1982:473-479.
35. Cummings, J. L. The Neuropsychiatrie Inventory: Assessing psychopathology in dementia patients. Neurology S10-6; 1997.
36. Davies, P. Strategies for the development of therapeutics for Alzheimer's disease. Neurobiol. Aging 15:853-4; 1994.
37. Dickson, D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:321-39; 1997.
38. Divry, P. Etude histochimique des plaques seniles. J. Beige. Neurol. 27:643-657; 1927.
39. Divry, P. De la nature de l'alteration fibrillaire d'Alzheimer. J. Beige. Neurol. Psychiat. 34:197-201; 1934.
40. Doraiswamy, P. M.; Bieber, F.; Kaiser, L.; Krishnan, K. R.; Reuning, S. J.; Gulanski, B. The Alzheimer's Disease Assessment Scale: Patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 48:1511-7; 1997.
41. Eikelenboom, P.; Veerhuis, R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 17:673-80; 1996.
42. English, W. H. Alzheimer's disease. Psychiat. Quart. 16:91-106; 1942.
43. Feldman, R. G.; Chandler, A. C.; Levy, L. L.; Glaser, G. H. Familial Alzheimer's disease. Neurology 13:811-824; 1963.
44. Ferraro, A. The origin and formation of senile plaques. Arch. Neurol. Psychiatr. 25:1042-1062; 1931.
45. Field, E. J. Amyloidosis, Alzheimer's disease, and ageing. Lancet 2:780-1; 1970.
46. Fischer, O. Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Mschr. Psychiat. Neurol. 22:361-372; 1907.
47. Flügel, F. E. Zur Diagnostik der Alzheimerschen Krankheit. Z. ges. Neurol. Psychiat. 120:783-787; 1929.
48. Forstl, H.; Howard, R. Recent studies on dementia senilis and brain disorders caused by atheromatous vascular disease: by A. Alzheimer, 1898. Alz. Dis. Assoc. Dis. 5:257-64; 1991.
49. Fuller, S. C. A study of the miliary plaques in brains of the aged. Am. J. Insan. 68:147-217; 1911.
50. Gellerstedt, N. Zur Kenntnis der Hirn veränderungen bei der normalen Altersinvolution. Uppsala. Lak. Foren. Forrh. 38:193-408; 1933.
51. Gorman, A. M.; McGowan, A.; O'Neill, C.; Cotter, T. Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 45-52; 1996.
52. Grünthal, E. In: Bumke, O., ed. Handbuch der Geistenkrankheiten. Berlin: 1930:638.
53. Gurwitz, D. Auguste D and Alzheimer's disease [letter]. Lancet 350:298; 1997.
54. Hachinski, V. Binswanger's disease: Neither Binswanger's nor a disease [editorial]. J. Neurol. Sci. 103:1; 1991.
55. Halpert, B. P. Development of the term "senility" as a medical diagnosis. Minn. Med. 66:421-4; 1983.
56. Hamann, C. Auguste D and Alzheimer's disease [letter]. Lancet 350:297-8; 1997.
57. Haymaker, W.; Schiller, F.; The Founders of Neurology. Springfield, Illinois: Charles C. Thomas; 1970.
58. Hemphill, R. F.; Stengel, E. Alzheimer's disease with predominating crossed cerebro-cerebellar hemiatrophy. J. Neurol. Psychiat. 4:97-106; 1941.
59. Henderson, D. K.; Maclachlan, S. H. Alzheimer's disease. J. Ment. Sei. 76:646-661; 1930.
60. Henderson, V. W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology S27-35; 1997.
61. Hull, M.; Fiebich, B. L.; Lieb, K.; Strauss, S.; Berger, S. S.; Volk, B.; Bauer, J. Interleukin-6 (IL-6)-associated inflammatory processes in Alzheimer's disease: New therapeutic options. Neurobiol. Aging 17:795-800; 1996.
62. Hunter, R.; Macalpine, I.,Three Hundred Years of Psychiatry (1535-1860): A history presented in selected English texts. Hartsdale, New York: Carlisle Publishing; 1982.
63. Hyman, B. T. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology [editorial]. Ann. Neurol. 40:135-6; 1996.
64. Inouye, S. K.; Albert, M. S.; Mohs, R.; Sun, K.; Berkman, L. F. Cognitive performance in a high-functioning community-dwelling elderly population. J. Gerontol. 48:M146-51; 1993.
65. Jameson, T. Essays on the Changes of the Human Body and its Different Ages. London: J. G. Bernard; 1811.
66. Jervis, G. A.; Soltz, S. E. Alzheimer's disease-the so-called juvenile type. Am. J. Psychiatry 93:39-56; 1936.
67. Jonkman, E. J. The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: An attempt at technology assessment. Neurophysiol. Clin. 27:211-9; 1997.
68. Kalaria, R. N.; Harshbarger, K. M.; Cohen, D. L.; Premkumar, D. R. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol. Aging 17:687-93; 1996.
69. Katzman, R. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch. Neurol. 33:217-8; 1976.
70. Katzman, R. Senile dementia of the Alzheimer type - defining a disease. In: Maddox, G. L.; Auld, E., eds. Proceedings of seminars 1976-1980. Durham, N.C.: Duke University council on Aging; 1981:19-40.
71. Katzman, R.; Galasko, D.; Saitoh, T.; Thal, L. J.; Hansen, L. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn. 28:259-65; 1995.
72. Katzman, R.; Suzuki, K. A search for a chemical correlate of amyloid in senile plaques of Alzheimer's disease. Trans. Am. Neurol. Assoc. 89:17-20; 1964.
73. Kawas, C.; Resnick, S.; Morrison, A.; Brookmeyer, R.; Corrada, M.; Zonderman, A.; Bacal, C.; Lingle, D. D.; Metter, E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48:1517-21; 1997.
74. Kesslak, J. P.; Nalcioglu, O.; Cotman, C. W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease [see comments]. Neurology 41:51-4; 1991.
75. Khachaturian, Z. S. Calcium hypothesis of Alzheimer's disease and brain aging. Ann. N. Y. Acad. Sci. 747:1-11; 1994.
76. Kidd, M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197:192-3; 1963.
77. Kidd, M. Alzheimer's disease-an electron microscopy of Alzheimer's disease. Brain 87:307-320; 1964.
78. Kraepelin, E. Das senile und präsenile Irresein, eds. Psychiatrie: Ein Lehrbuch für Studierende und Arzte. Leipzig: Johann Ambrosius Barth; 1910:533-632.
79. Krigman, M. R. Alzheimer's presenile dementia. Lab. Invest. 14: 381-396; 1965.
80. Kusiak, J. W.; Izzo, J. A.; Zhao, B. Neurodegeneration in Alzheimer disease. Is apoptosis involved? Mol. Chem. Neuropathol. 28:153-62; 1996.
81. Lowenberg, K. Die Histopathologie und Histogenese der Plaques Seniles. Z. ges. Neurol. Psychiat. 98:549; 1925.
82. Lowenberg, K.; Waggoner, R. W. Familial organic psychosis (Alzheimer's type). Arch. Neurol. Psychiat. 31:737-754; 1934.
83. Ma, J.; Brewer, H. J.; Potter, H. Alzheimer A beta neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by A β-related peptides. Neurobiol. Aging 17:773-80; 1996.
84. Magner, L. N.; A History of Medicine. New York, New York: Marcel Dekker, Inc; 1992.
85. Mahendra, B.; Dementia, a Survey of the Syndrome of Dementia. Lancaster, England: MTP Press Limited; 1987.
86. Margolis, G. Senile cerebral disease. A critical survey of traditional concepts based upon observations with newer techniques. Lab. Invest. 8:335-370; 1959.
87. Marx, J. Searching for drugs that combat Alzheimer's [news]. Science 273:50-3; 1996.
88. Mast, H.; Tatemichi, T. K.; Mohr, J. P. Chronic brain ischemia: The contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia. J. Neurol. Sci. 132:4-10; 1995.
89. Masterman, D. L.; Mendez, M. F.; Fairbanks, L. A.; Cummings, J. L. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J. Geriatr. Psychiatry Neurol. 10:15-21; 1997.
90. Mattson, M. P. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging 16:447-57; discussion 458-63; 1995.
91. Maurer, K.; Volk, S.; Gerbaldo, H. Auguste D and Alzheimer's disease. Lancet 349:1546-9; 1997.
92. Mayeux, R.; Ottman, R.; Maeslre, G.; Ngai, C.; Tang, M. X.; Ginsberg, H.; Chun, M.; Tycko, B.; Shelanski, M. Synergislic effects of Iraumalic head injury and apolipoprolein-∈ 4 in palienls with Alzheimer's disease [see commenls]. Neurology 555-7; 1995.
93. McBee, W. L.; Dailey, M. E.; Dugan, E.; Shumaker, S. A. Hormone replacemenl therapy and olher polenlial Irealmenls for demenlias. Endocrinol. Melab. Clin. North Am. 26:329-45; 1997.
94. McGeer, P. L.; McGeer, E. G. The inflammatory response system of brain: Implicalions for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:195-218; 1995.
95. McGeer, P. L.; McGeer, E. G. Anli-inflammalory drugs in the fight againsl Alzheimer's disease. Ann. N. Y. Acad. Sci. 777:213-20; 1996.
96. McGrew, R. E. Encyclopedia of Medical History. USA: Roderick E. McGrew; 1985.
97. McMenemey, W. The demenlias and progressive diseases of the basal ganglia. In: Greenfield, J.; Blackwood, W.; Mcmenemey, W.; et al., eds. Greenfield's Neuropalhology. London: Arnold; 1963:520-546.
98. McMenemey, W. H. Alzheimer's disease. J. Neurol. Psych. 3:211-240; 1940.
99. McMenemey, W. H. Dementia in Middle Age: A crilical review. J. Neurol. Psych. 4:48-79; 1941.
100. Mulrux, S. Conlribulion a l'élude des corrélalions analomo-cliniques dans les démences dégénéralives el les démences arlérioscléreuses. Mschr. Psychial. Neurol. 125:19-38; 1953.
101. Mulrux, S. Conlribulion à l'élude hislologique differenliale de la démence sénile el de la maladie d'Alzheimer. Mschr. Psychial. Neurol. 136:157-194; 1958.
102. Newberg, A. B.; Alavi, A. The sludy of neurological disorders using posilron emission tomography and single photon emission computed tomography. J. Neurol. Sci. 135:91-108; 1996.
103. Newton, R. D. The idenlily of Alzheimer's disease and senile demenlia and their relalionship to senilily. Alzheimer's Disease and Senile Demenlia 225-248; 1947.
104. Nishimolo, I.; Okamolo, T.; Giambarella, U.; Iwalsubo, T. Apoplosis in neurodegeneralive diseases. Adv. Pharmacol. 41:337-68; 1997.
105. Nordberg, A. Applicalion of PET in demenlia disorders. Acta Neurol. Scand. Suppl. 168:71-6; 1996.
106. O'Banion, M. K.; Finch, C. E. Inflammatory mechanisms and anli-inflammalory Iherapy in Alzheimer's disease [editorial]. Neurobiol. Aging 17:669-71; 1996.
107. O'Brien, C. Augusle D and Alzheimer's disease [news]. Science 273:28; 1996.
108. Pasinetti, G. M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system. Neurobiol. Aging 17:707-16; 1996.
109. Pereira, H. A.; Kumar, P.; Grammas, P. Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol. Aging 17:753-9; 1996.
110. Perusini, G. Uber klinisch und histologisch eigenartige psychische Erkrankungen des späteren Lebensalters. Histologische und histopathologische Arbeiten 3:297-351; 1910.
111. Perusini, G. Sul valore nosografico di alcuni reperti istopatologici caratteristici per la senilitá. Rivista italiana di Neuropathologia, Psichiatria ed Elettroterapia 4:193-213; 1911.
112. Pinel, P. A treatise on insanity. In: Hunter, R.; Macalpine, I., eds. Three Hundred Years of Psychiatry (1535-1860). Hartsdale, NY: Carlisle Publishing, Inc.; 1806:602-610.
113. Post, S. G.; Whitehouse, P. J.; Binstock, R. H.; Bird, T. D.; Eckert, S. K.; Farrer, L. A.; Fleck, L. M.; Gaines, A. D.; Juengst, E. T.; Karlinsky, H.; Miles, S.; Murray, T. H.; Quaid, K. A.; Relkin, N. R.; Roses, A. D.; St George-Hyslop, P.; Sachs, G. A.; Steinbock, B.; Truschke, E. F.; Zinn, A. B. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA 227: 832-6; 1997.
114. Rankin, L. Alzheimer's disease: New horizons in diagnosis and treatment. Iowa Med. 87:199-201; 1997.
115. Rath, G. Neural pathology: A pathogenic concept of the 18th and 19th centuries. Bull. Hist. Med. 33:526-541; 1959.
116. Redlich, E. Ueber miliare Sklerose der Hirnrinde bei seniler Atrophie. J. Psychiat. Neurol. 17:208-216; 1898.
117. Rhodes, P. An Outline History of Medicine. Cambridge, England: University Press; 1985.
118. Rieh, J. B.; Rasmusson, D. X.; Folstein, M. F.; Carson, K. A.; Kawas, C.; Brandt, J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease [see comments]. Neurology 45:51-5; 1995.
119. Rogers, J.; Kirby, L. C.; Hempelman, S. R.; Berry, D. L.; McGeer, P. L.; Kaszniak, A. W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Willson, P.; et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-11; 1993.
120. Rogers, J.; Webster, S.; Lue, L. F.; Brachova, L.; Civin, W. H.; Emmerling, M.; Shivers, B.; Walker, D.; McGeer, P. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17:681-6; 1996.
121. Roses, A. D. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease [see comments]. J. Neuropathol. Exp. Neurol. 53:429-37; 1994.
122. Roses, A. D. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease [see comments]. Ann. Neurol. 38:6-14; 1995.
123. Roses, A. D.; Saunders, A. M. APOE is a major susceptibility gene for Alzheimer's disease. Curr. Opin. Biotechnol. 5:663-7; 1994.
124. Roth, M. The natural history of mental disorder in old age. J. Ment. Sci. 101:281-301; 1955.
125. Roth, M. The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. Brit. Med. Bull. 42:42-50; 1986.
126. Roth, M.; Morrissey, J. D. Problems in the diagnosis and classification of mental disease in old age with a study of case material. J. Ment. Sci. 99:439-448; 1952.
127. Roth, M.; Tomlinson, B. E.; Blessed, G. Correlation between scores for dementia and counts of 'senile plaques' in cerebral gray matter of elderly subjects. Nature 209:109-10; 1966.
128. Roth, M.; Tomlinson, B. E.; Blessed, G. The relationship between quantitative measures of dementia and of degenerative changes in the cerebral gray matter of elderly subjects. Proc. R. Soc. Med. 60:254-60; 1967.
129. Rothschild, D.; Kasanin, J. Clinicopathologic study of Alzheimer's disease: relationship to senile condition. Arch. Neurol. Psychiat. 36:293-321; 1936.
130. Ryding, E. SPECT measurements of brain function in dementia; a review. Acta Neurol. Scand. Suppl. 168:54-8; 1996.
131. Sandson, T. A.; Price, B. H. Diagnostic testing and dementia. Neurol. Clin. 14:45-59; 1996.
132. Sano, M.; Ernesto, C.; Thomas, R. G.; Klauber, M. R.; Schafer, K.; Grundman, M.; Woodbury, P.; Growdon, J.; Cotman, C. W.; Pfeiffer, E.; Schneider, L. S.; Thal, L. J. A controlled trial of selegiline, a-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study [see comments]. N. Engl. J. Med. 336:1216-22; 1997.
133. Schellenberg, G. D. Progress in Alzheimer's disease genetics. Curr. Opin. Neurol. 8:262-7; 1995.
134. Schneider, R.; Wieczorek, V. Historical aspects of neurosciences. Otto Binswanger (1852-1929). J. Neurol. Sei. 103:61-4; 1991.
135. Schorer. Historical essay: Kraepelin's description of Alzheimer's disease. Int. J. Aging Human Dev. 21:235-238; 1985.
136. Schottky, J. Uber präsenile Verblödungen. Z. ges. Neurol. Psychiat. 140:333-397; 1932.
137. Seeman, T. E.; Berkman, L. F.; Charpentier, P. A.; Blazer, D. G.; Albert, M. S.; Tinetti, M. E. Behavioral and psychosocial predictors of physical performance: MacArthur studies of successful aging. J. Gerontol. A. Biol. Sci. Med. Sci. 50:M177-83; 1995.
138. Selkoe, D. J. Alzheimer's disease: A central role for amyloid [see comments]. J. Neuropathol. Exp. Neurol. 53:438-47; 1994.
139. Selkoe, D. J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:18295-8; 1996.
140. Shakespeare, W. Hamlet. In: Harbage, A., ed. William Shake-speare-The Complete Works. New York: Viking Penguin; 1977: 1107-1135.
141. Sheng, J. G.; Ito, K.; Skinner, R. D.; Mrak, R. E.; Rovnaghi, C. R.; Van, E. L.; Griffin, W. S. In vivo and in vitro evidence supporting a role for the inflammatory cytokine IL-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17:761-6; 1996.
142. Simchowicz, T. Histologische Studien über die senile Demenz. Hist, histopath. Arb. 4:267-444; 1910.
143. Simonian, N. A.; Coyle, J. T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:83-106; 1996.
144. Singer, C. A Short History of Medicine. New York: Oxford University Press; 1928.
145. Small, G. W. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. J. Clin. Psychiatry. 14:9-13; 1996.
146. Smith, A. D.; Jobst, K. A. Use of structural imaging to study the progression of Alzheimer's disease. Br. Med. Bull. 52:575-86; 1996.
147. Smith, C. D. Quantitative computed tomography and magnetic resonance imaging in aging and Alzheimer's disease. A review. J. Neuroimaging 6:44-53; 1996.
148. Smith, M. A.; Sayre, L. M.; Monnier, V. M.; Perry, G. Radical AGEing in Alzheimer's disease [see comments]. Trends Neurosci. 18:172-6; 1995.
149. Summers, W. K.; Tachiki, K. H.; Kling, A. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Eur. Neurol. 3:28-32; 1989.
150. Terry, R., D.; Gonatas, N. K.; Weiss, M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44:269-281; 1964.
151. Terry, R. D. The fine structure of neurofibrillary tangles in Alzheimer's disease. J. Neuropath. Exp. Neurol. 22:629-642; 1963.
152. Terry, R. D. The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55:1023-5; 1996.
153. Torack, R. The early history of senile dementia. In: Reisberg, B., eds. Alzheimer's Disease. New York: The Free Press; 1983:23-28.
154. Torack, R. M.; The Pathologic Physiology of Dementia. New York: Springer-Verlag; 1978.
155. Trojanowski, J. Q.; Lee, V. M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases. FASEB J. 9:1570-6; 1995.
156. Trojanowski, J. Q.; Shin, R. W.; Schmidt, M. L.; Lee, V. M. Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease. Neurobiol. Aging 16:335-40; discussion 341-5; 1995.
157. van Braunmühl, A. Neue Gesichtspunkte zum Problem der senilen Plaques. Z ges. Neurol. Psychiat. 133:391-441; 1931.
158. van Swieten, J. C.; Caplan, L. R. Binswanger's disease. Adv. Neurol. 62:193-211; 1993.
159. Venzmer, G. 5000 Years of Medicine. New York: Taplinger Publishing Co., Inc; 1968.
160. Wahlund, L. O. Biological markers and diagnostic investigations in Alzheimer's disease. Acta Neurol. Scand. Suppl. 165:85-91; 1996.
161. Wahlund, L. O. Magnetic resonance imaging and computed tomography in Alzheimer's disease. Acta Neurol. Scand. Suppl. 168:50-3; 1996.
162. Walford, R. L. The role of autoimmune phenomena in the ageing process. Symp. Soc. Exp. Biol. 21:351-73; 1967.
163. Wallin, A.; Blennow, K. Clinical subgroups of the Alzheimer syndrome. Acta Neurol. Scand. Suppl. 165:51-7; 1996.
164. Wilkins, R. H.; Brody, I. A. Alzheimer's disease. Arch. Neurol. 21:109-10; 1969.
165. Wilks, S. Clinical notes on atrophy of the brain. J. Ment. Sci. 10:10-19; 1864.
166. Willis, T. Practice of Physick (1684). In: Hunter, R.; Macalpaine, I., eds. Three Hundred Years of Psychiatry (1535-1860): A history presented in selected English texts. Hartsdale, New York: Carlisle Publishing; 1982:189-192.
167. Wisniewski, H. M.; Wegiel, J.; Kotula, L. Review. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22:3-11; 1996.
168. Wisniewski, T.; Frangione, B. Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol. Exp. (Warsz.) 56:267-79; 1996.
169. Xanthakos, S.; Krishnan, K. R.; Kim, D. M.; Charles, H. C. Magnetic resonance imaging of Alzheimer's disease. Prog. Neuropsychopharmacol Biol. Psychiatry 20:597-626; 1996.
170. Yen, S. H.; Liu, W. K.; Hall, F. L.; Yan, S. D.; Stern, D.; Dickson, D. W. Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components. Neurobiol. Aging 16:381-7; 1995.